EVOGENE LTD (EVGN) Stock Price & Overview
NASDAQ:EVGN • IL0011050551
Current stock price
The current stock price of EVGN is 0.8529 USD. Today EVGN is up by 0.6%. In the past month the price decreased by -3.3%. In the past year, price decreased by -35.28%.
EVGN Key Statistics
- Market Cap
- 7.437M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.17
- Dividend Yield
- N/A
EVGN Stock Performance
EVGN Stock Chart
EVGN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to EVGN. When comparing the yearly performance of all stocks, EVGN is a bad performer in the overall market: 87.4% of all stocks are doing better.
EVGN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to EVGN. EVGN may be in some trouble as it scores bad on both profitability and health.
EVGN Earnings
On March 5, 2026 EVGN reported an EPS of -0.61 and a revenue of 314.00K. The company missed EPS expectations (-130.02% surprise) and beat revenue expectations (11.94% surprise).
EVGN Forecast & Estimates
7 analysts have analysed EVGN and the average price target is 2.55 USD. This implies a price increase of 198.98% is expected in the next year compared to the current price of 0.8529.
For the next year, analysts expect an EPS growth of -17.69% and a revenue growth -61.68% for EVGN
EVGN Groups
Sector & Classification
EVGN Financial Highlights
Over the last trailing twelve months EVGN reported a non-GAAP Earnings per Share(EPS) of -1.17. The EPS increased by 62.38% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -42.33% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EVGN Ownership
EVGN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.96 | 366.329B | ||
| AMGN | AMGEN INC | 15.33 | 190.793B | ||
| GILD | GILEAD SCIENCES INC | 15.66 | 171.639B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.2 | 115.576B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.03 | 79.234B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 44.2 | 43.592B | ||
| INSM | INSMED INC | N/A | 31.968B | ||
| NTRA | NATERA INC | N/A | 27.973B | ||
| BIIB | BIOGEN INC | 11.74 | 27.764B | ||
| UTHR | UNITED THERAPEUTICS CORP | 18.06 | 23.738B | ||
| MRNA | MODERNA INC | N/A | 21.145B | ||
| EXAS | EXACT SCIENCES CORP | 345.14 | 20.026B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 18.686B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About EVGN
Company Profile
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Company Info
IPO: 2007-06-11
EVOGENE LTD
13 Gad Feinstein Street, Park Rehovot
Rehovot 7414002 IL
CEO: Ofer Haviv
Employees: 117
Phone: 97289311900
EVOGENE LTD / EVGN FAQ
Can you describe the business of EVOGENE LTD?
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Can you provide the latest stock price for EVOGENE LTD?
The current stock price of EVGN is 0.8529 USD. The price increased by 0.6% in the last trading session.
Does EVOGENE LTD pay dividends?
EVGN does not pay a dividend.
How is the ChartMill rating for EVOGENE LTD?
EVGN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the employee count for EVGN stock?
EVOGENE LTD (EVGN) currently has 117 employees.
When does EVOGENE LTD (EVGN) report earnings?
EVOGENE LTD (EVGN) will report earnings on 2026-05-19.
Can you provide the ownership details for EVGN stock?
You can find the ownership structure of EVOGENE LTD (EVGN) on the Ownership tab.